Skip to main content

Table 2 Cross resistances of P.aeruginosa isolates.

From: Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey

Isolates resistant

 

number of isolates resistant to

To

n

IP

MP

PM

TZ

CFS

PTc

Cl

TM

AK

IP

35

 

34 (97)

17 (49)

11 (31)

22 (63)

25 (71)

8 (23)

30 (86)

9 (26)

MP

36

34 (94)

 

18 (50)

12 (33)

23 (64)

27 (75)

9 (25)

32 (89)

10 (28)

PM

28

17 (61)

18 (64)

 

19 (68)

18 (64)

19 (68)

13 (46)

23 (82)

13 (46)

TZ

22

11 (50)

12 (55)

19 (86)

 

13 (59)

15 (68)

11 (50)

16 (73)

8 (36)

CFS

32

22 (69)

23 (72)

18 (56)

13 (41)

 

22 (69)

9 (28)

30 (94)

11 (34)

PTc

36

25 (69)

27 (75)

19 (53)

15 (42)

22 (61)

 

7 (19)

29 (81)

13 (36)

Cl

20

8 (40)

9 (45)

13 (65)

11 (55)

9 (45)

7 (35)

 

17 (85)

7 (35)

TM

51

30 (59)

32 (63)

23 (45)

16 (31)

30 (59)

29 (57)

17 (33)

 

18 (35)

AK

20

9 (45)

10 (50)

13 (65)

8 (40)

11 (55)

13 (65)

7 (35)

18 (90)

 
  1. IP: imipenem, MP: meropenem, PM: cefepime, TZ: ceftazidime, CFS: cefoperazone/sulbactam, PTc: piperacillin/tazobactam, Cl: ciprofloxacin, TM: tobramycin, AK: amikacin. *The numbers in parentheses denote percent of isolates